Protective efficacy of intranasal cold-adapted influenza A/New Caledonia/20/99 (H1N1) vaccines comprised of egg- or cell culture-derived reassortants.
Identifieur interne : 001653 ( Main/Exploration ); précédent : 001652; suivant : 001654Protective efficacy of intranasal cold-adapted influenza A/New Caledonia/20/99 (H1N1) vaccines comprised of egg- or cell culture-derived reassortants.
Auteurs : Thomas Palker [États-Unis] ; Irina Kiseleva ; Kimberly Johnston ; Qin Su ; Timothy Toner ; Christopher Szymkowiak ; Wan-Sang Kwan ; Boris Rubin ; Luba Petrukhin ; Joan Wlochowski ; Juanita Monteiro ; Nikolai Kraiouchkine ; Daniel Distefano ; Larisa Rudenko ; Alan Shaw ; Rima YouilSource :
- Virus research [ 0168-1702 ] ; 2004.
Descripteurs français
- KwdFr :
- Administration par voie nasale, Animaux, Chiens, Embryon de poulet, Furets, Glycoprotéine hémagglutinine du virus influenza (génétique), Infections à Orthomyxoviridae (), Infections à Orthomyxoviridae (immunologie), Lignée cellulaire, Liquide de lavage bronchoalvéolaire (virologie), Liquide de lavage nasal (virologie), Modèles animaux de maladie humaine, Méthode des plages virales, Protéines virales (génétique), Sialidase (génétique), Sous-type H1N1 du virus de la grippe A, Vaccination, Vaccins antigrippaux (administration et posologie), Vaccins antigrippaux (immunologie), Virus de la grippe A (croissance et développement), Virus de la grippe A (génétique), Virus de la grippe A (immunologie), Virus recombinants (croissance et développement), Virus recombinants (génétique), Virus recombinants (immunologie).
- MESH :
- administration et posologie : Vaccins antigrippaux.
- croissance et développement : Virus de la grippe A, Virus recombinants.
- génétique : Glycoprotéine hémagglutinine du virus influenza, Protéines virales, Sialidase, Virus de la grippe A, Virus recombinants.
- immunologie : Infections à Orthomyxoviridae, Vaccins antigrippaux, Virus de la grippe A, Virus recombinants.
- virologie : Liquide de lavage bronchoalvéolaire, Liquide de lavage nasal.
- Administration par voie nasale, Animaux, Chiens, Embryon de poulet, Furets, Infections à Orthomyxoviridae, Lignée cellulaire, Modèles animaux de maladie humaine, Méthode des plages virales, Sous-type H1N1 du virus de la grippe A, Vaccination.
English descriptors
- KwdEn :
- Administration, Intranasal, Animals, Bronchoalveolar Lavage Fluid (virology), Cell Line, Chick Embryo, Disease Models, Animal, Dogs, Ferrets, Hemagglutinin Glycoproteins, Influenza Virus (genetics), Influenza A Virus, H1N1 Subtype, Influenza A virus (genetics), Influenza A virus (growth & development), Influenza A virus (immunology), Influenza Vaccines (administration & dosage), Influenza Vaccines (immunology), Nasal Lavage Fluid (virology), Neuraminidase (genetics), Orthomyxoviridae Infections (immunology), Orthomyxoviridae Infections (prevention & control), Reassortant Viruses (genetics), Reassortant Viruses (growth & development), Reassortant Viruses (immunology), Vaccination, Viral Plaque Assay, Viral Proteins (genetics).
- MESH :
- chemical , administration & dosage : Influenza Vaccines.
- chemical , genetics : Hemagglutinin Glycoproteins, Influenza Virus, Neuraminidase, Viral Proteins.
- genetics : Influenza A virus, Reassortant Viruses.
- growth & development : Influenza A virus, Reassortant Viruses.
- immunology : Influenza A virus, Influenza Vaccines, Orthomyxoviridae Infections, Reassortant Viruses.
- prevention & control : Orthomyxoviridae Infections.
- virology : Bronchoalveolar Lavage Fluid, Nasal Lavage Fluid.
- Administration, Intranasal, Animals, Cell Line, Chick Embryo, Disease Models, Animal, Dogs, Ferrets, Influenza A Virus, H1N1 Subtype, Vaccination, Viral Plaque Assay.
Abstract
Live, cold-adapted, temperature-sensitive (ca/ts) Russian influenza A vaccines are prepared in eggs by a 6:2 gene reassortment of the ca/ts donor strain A/Leningrad/134/17/57 (H2N2) (Len/17) with a current wild-type (wt) influenza A strain contributing hemagglutinin (HA) and neuraminidase (NA) genes. However, egg-derived reassortant vaccines are potentially more problematic to manufacture in large quantities than vaccines from cell-based procedures. To compare egg- and cell culture-derived reassortant vaccines, we prepared in Madin Darby canine kidney (MDCK) cells two cloned, ca/ts reassortants (25M/1, 39E/2) derived from Len/17 and a wt reference strain A/New Caledonia/20/99 (H1N1) (NC/wt). Both 25M/1 and 39E/2 reassortants preserved the ca/ts phenotype and mutations described for internal genes of the A/Len/17 parent. When compared to a commercial, egg-derived ca/ts Russian A/17/NC/99/145 (H1N1) New Caledonia vaccine (NC/145), the MDCK-derived reassortant 39E/2 vaccine conferred similar levels of protection in ferrets challenged i.n. with 7 x 10(10) pfu of NC/wt. In a dose-ranging study, the protective vaccine dose for 50% of ferrets (PD50) was less than 1.2 x 10(4) pfu for the 25M/1 vaccine derived by recombination and amplification in MDCK cells. Clonal isolates of ca/ts influenza A/New Caledonia/20/99 (H1N1) obtained by recombination and amplification entirely in MDCK cells can be highly protective i.n. vaccines.
DOI: 10.1016/j.virusres.2004.05.009
PubMed: 15351492
Affiliations:
Links toward previous steps (curation, corpus...)
- to stream PubMed, to step Corpus: 000326
- to stream PubMed, to step Curation: 000326
- to stream PubMed, to step Checkpoint: 000297
- to stream Ncbi, to step Merge: 000109
- to stream Ncbi, to step Curation: 000109
- to stream Ncbi, to step Checkpoint: 000109
- to stream Main, to step Merge: 001683
- to stream Main, to step Curation: 001653
Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Protective efficacy of intranasal cold-adapted influenza A/New Caledonia/20/99 (H1N1) vaccines comprised of egg- or cell culture-derived reassortants.</title><author><name sortKey="Palker, Thomas" sort="Palker, Thomas" uniqKey="Palker T" first="Thomas" last="Palker">Thomas Palker</name><affiliation wicri:level="1"><nlm:affiliation>Department of Virus and Cell Biology, Vaccine and Biologics Research, Merck Research Laboratories, Merck and Co., Inc., 770 Sumneytown Pike, WP16-101, West Point, PA 19486, USA. tom_palker@merck.com</nlm:affiliation><country xml:lang="fr">États-Unis</country><wicri:regionArea>Department of Virus and Cell Biology, Vaccine and Biologics Research, Merck Research Laboratories, Merck and Co., Inc., 770 Sumneytown Pike, WP16-101, West Point, PA 19486</wicri:regionArea><wicri:noRegion>PA 19486</wicri:noRegion></affiliation></author><author><name sortKey="Kiseleva, Irina" sort="Kiseleva, Irina" uniqKey="Kiseleva I" first="Irina" last="Kiseleva">Irina Kiseleva</name></author><author><name sortKey="Johnston, Kimberly" sort="Johnston, Kimberly" uniqKey="Johnston K" first="Kimberly" last="Johnston">Kimberly Johnston</name></author><author><name sortKey="Su, Qin" sort="Su, Qin" uniqKey="Su Q" first="Qin" last="Su">Qin Su</name></author><author><name sortKey="Toner, Timothy" sort="Toner, Timothy" uniqKey="Toner T" first="Timothy" last="Toner">Timothy Toner</name></author><author><name sortKey="Szymkowiak, Christopher" sort="Szymkowiak, Christopher" uniqKey="Szymkowiak C" first="Christopher" last="Szymkowiak">Christopher Szymkowiak</name></author><author><name sortKey="Kwan, Wan Sang" sort="Kwan, Wan Sang" uniqKey="Kwan W" first="Wan-Sang" last="Kwan">Wan-Sang Kwan</name></author><author><name sortKey="Rubin, Boris" sort="Rubin, Boris" uniqKey="Rubin B" first="Boris" last="Rubin">Boris Rubin</name></author><author><name sortKey="Petrukhin, Luba" sort="Petrukhin, Luba" uniqKey="Petrukhin L" first="Luba" last="Petrukhin">Luba Petrukhin</name></author><author><name sortKey="Wlochowski, Joan" sort="Wlochowski, Joan" uniqKey="Wlochowski J" first="Joan" last="Wlochowski">Joan Wlochowski</name></author><author><name sortKey="Monteiro, Juanita" sort="Monteiro, Juanita" uniqKey="Monteiro J" first="Juanita" last="Monteiro">Juanita Monteiro</name></author><author><name sortKey="Kraiouchkine, Nikolai" sort="Kraiouchkine, Nikolai" uniqKey="Kraiouchkine N" first="Nikolai" last="Kraiouchkine">Nikolai Kraiouchkine</name></author><author><name sortKey="Distefano, Daniel" sort="Distefano, Daniel" uniqKey="Distefano D" first="Daniel" last="Distefano">Daniel Distefano</name></author><author><name sortKey="Rudenko, Larisa" sort="Rudenko, Larisa" uniqKey="Rudenko L" first="Larisa" last="Rudenko">Larisa Rudenko</name></author><author><name sortKey="Shaw, Alan" sort="Shaw, Alan" uniqKey="Shaw A" first="Alan" last="Shaw">Alan Shaw</name></author><author><name sortKey="Youil, Rima" sort="Youil, Rima" uniqKey="Youil R" first="Rima" last="Youil">Rima Youil</name></author></titleStmt><publicationStmt><idno type="wicri:source">PubMed</idno><date when="2004">2004</date><idno type="RBID">pubmed:15351492</idno><idno type="pmid">15351492</idno><idno type="doi">10.1016/j.virusres.2004.05.009</idno><idno type="wicri:Area/PubMed/Corpus">000326</idno><idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">000326</idno><idno type="wicri:Area/PubMed/Curation">000326</idno><idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Curation">000326</idno><idno type="wicri:Area/PubMed/Checkpoint">000297</idno><idno type="wicri:explorRef" wicri:stream="Checkpoint" wicri:step="PubMed">000297</idno><idno type="wicri:Area/Ncbi/Merge">000109</idno><idno type="wicri:Area/Ncbi/Curation">000109</idno><idno type="wicri:Area/Ncbi/Checkpoint">000109</idno><idno type="wicri:doubleKey">0168-1702:2004:Palker T:protective:efficacy:of</idno><idno type="wicri:Area/Main/Merge">001683</idno><idno type="wicri:Area/Main/Curation">001653</idno><idno type="wicri:Area/Main/Exploration">001653</idno></publicationStmt><sourceDesc><biblStruct><analytic><title xml:lang="en">Protective efficacy of intranasal cold-adapted influenza A/New Caledonia/20/99 (H1N1) vaccines comprised of egg- or cell culture-derived reassortants.</title><author><name sortKey="Palker, Thomas" sort="Palker, Thomas" uniqKey="Palker T" first="Thomas" last="Palker">Thomas Palker</name><affiliation wicri:level="1"><nlm:affiliation>Department of Virus and Cell Biology, Vaccine and Biologics Research, Merck Research Laboratories, Merck and Co., Inc., 770 Sumneytown Pike, WP16-101, West Point, PA 19486, USA. tom_palker@merck.com</nlm:affiliation><country xml:lang="fr">États-Unis</country><wicri:regionArea>Department of Virus and Cell Biology, Vaccine and Biologics Research, Merck Research Laboratories, Merck and Co., Inc., 770 Sumneytown Pike, WP16-101, West Point, PA 19486</wicri:regionArea><wicri:noRegion>PA 19486</wicri:noRegion></affiliation></author><author><name sortKey="Kiseleva, Irina" sort="Kiseleva, Irina" uniqKey="Kiseleva I" first="Irina" last="Kiseleva">Irina Kiseleva</name></author><author><name sortKey="Johnston, Kimberly" sort="Johnston, Kimberly" uniqKey="Johnston K" first="Kimberly" last="Johnston">Kimberly Johnston</name></author><author><name sortKey="Su, Qin" sort="Su, Qin" uniqKey="Su Q" first="Qin" last="Su">Qin Su</name></author><author><name sortKey="Toner, Timothy" sort="Toner, Timothy" uniqKey="Toner T" first="Timothy" last="Toner">Timothy Toner</name></author><author><name sortKey="Szymkowiak, Christopher" sort="Szymkowiak, Christopher" uniqKey="Szymkowiak C" first="Christopher" last="Szymkowiak">Christopher Szymkowiak</name></author><author><name sortKey="Kwan, Wan Sang" sort="Kwan, Wan Sang" uniqKey="Kwan W" first="Wan-Sang" last="Kwan">Wan-Sang Kwan</name></author><author><name sortKey="Rubin, Boris" sort="Rubin, Boris" uniqKey="Rubin B" first="Boris" last="Rubin">Boris Rubin</name></author><author><name sortKey="Petrukhin, Luba" sort="Petrukhin, Luba" uniqKey="Petrukhin L" first="Luba" last="Petrukhin">Luba Petrukhin</name></author><author><name sortKey="Wlochowski, Joan" sort="Wlochowski, Joan" uniqKey="Wlochowski J" first="Joan" last="Wlochowski">Joan Wlochowski</name></author><author><name sortKey="Monteiro, Juanita" sort="Monteiro, Juanita" uniqKey="Monteiro J" first="Juanita" last="Monteiro">Juanita Monteiro</name></author><author><name sortKey="Kraiouchkine, Nikolai" sort="Kraiouchkine, Nikolai" uniqKey="Kraiouchkine N" first="Nikolai" last="Kraiouchkine">Nikolai Kraiouchkine</name></author><author><name sortKey="Distefano, Daniel" sort="Distefano, Daniel" uniqKey="Distefano D" first="Daniel" last="Distefano">Daniel Distefano</name></author><author><name sortKey="Rudenko, Larisa" sort="Rudenko, Larisa" uniqKey="Rudenko L" first="Larisa" last="Rudenko">Larisa Rudenko</name></author><author><name sortKey="Shaw, Alan" sort="Shaw, Alan" uniqKey="Shaw A" first="Alan" last="Shaw">Alan Shaw</name></author><author><name sortKey="Youil, Rima" sort="Youil, Rima" uniqKey="Youil R" first="Rima" last="Youil">Rima Youil</name></author></analytic><series><title level="j">Virus research</title><idno type="ISSN">0168-1702</idno><imprint><date when="2004" type="published">2004</date></imprint></series></biblStruct></sourceDesc></fileDesc><profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Administration, Intranasal</term><term>Animals</term><term>Bronchoalveolar Lavage Fluid (virology)</term><term>Cell Line</term><term>Chick Embryo</term><term>Disease Models, Animal</term><term>Dogs</term><term>Ferrets</term><term>Hemagglutinin Glycoproteins, Influenza Virus (genetics)</term><term>Influenza A Virus, H1N1 Subtype</term><term>Influenza A virus (genetics)</term><term>Influenza A virus (growth & development)</term><term>Influenza A virus (immunology)</term><term>Influenza Vaccines (administration & dosage)</term><term>Influenza Vaccines (immunology)</term><term>Nasal Lavage Fluid (virology)</term><term>Neuraminidase (genetics)</term><term>Orthomyxoviridae Infections (immunology)</term><term>Orthomyxoviridae Infections (prevention & control)</term><term>Reassortant Viruses (genetics)</term><term>Reassortant Viruses (growth & development)</term><term>Reassortant Viruses (immunology)</term><term>Vaccination</term><term>Viral Plaque Assay</term><term>Viral Proteins (genetics)</term></keywords><keywords scheme="KwdFr" xml:lang="fr"><term>Administration par voie nasale</term><term>Animaux</term><term>Chiens</term><term>Embryon de poulet</term><term>Furets</term><term>Glycoprotéine hémagglutinine du virus influenza (génétique)</term><term>Infections à Orthomyxoviridae ()</term><term>Infections à Orthomyxoviridae (immunologie)</term><term>Lignée cellulaire</term><term>Liquide de lavage bronchoalvéolaire (virologie)</term><term>Liquide de lavage nasal (virologie)</term><term>Modèles animaux de maladie humaine</term><term>Méthode des plages virales</term><term>Protéines virales (génétique)</term><term>Sialidase (génétique)</term><term>Sous-type H1N1 du virus de la grippe A</term><term>Vaccination</term><term>Vaccins antigrippaux (administration et posologie)</term><term>Vaccins antigrippaux (immunologie)</term><term>Virus de la grippe A (croissance et développement)</term><term>Virus de la grippe A (génétique)</term><term>Virus de la grippe A (immunologie)</term><term>Virus recombinants (croissance et développement)</term><term>Virus recombinants (génétique)</term><term>Virus recombinants (immunologie)</term></keywords><keywords scheme="MESH" type="chemical" qualifier="administration & dosage" xml:lang="en"><term>Influenza Vaccines</term></keywords><keywords scheme="MESH" type="chemical" qualifier="genetics" xml:lang="en"><term>Hemagglutinin Glycoproteins, Influenza Virus</term><term>Neuraminidase</term><term>Viral Proteins</term></keywords><keywords scheme="MESH" qualifier="administration et posologie" xml:lang="fr"><term>Vaccins antigrippaux</term></keywords><keywords scheme="MESH" qualifier="croissance et développement" xml:lang="fr"><term>Virus de la grippe A</term><term>Virus recombinants</term></keywords><keywords scheme="MESH" qualifier="genetics" xml:lang="en"><term>Influenza A virus</term><term>Reassortant Viruses</term></keywords><keywords scheme="MESH" qualifier="growth & development" xml:lang="en"><term>Influenza A virus</term><term>Reassortant Viruses</term></keywords><keywords scheme="MESH" qualifier="génétique" xml:lang="fr"><term>Glycoprotéine hémagglutinine du virus influenza</term><term>Protéines virales</term><term>Sialidase</term><term>Virus de la grippe A</term><term>Virus recombinants</term></keywords><keywords scheme="MESH" qualifier="immunologie" xml:lang="fr"><term>Infections à Orthomyxoviridae</term><term>Vaccins antigrippaux</term><term>Virus de la grippe A</term><term>Virus recombinants</term></keywords><keywords scheme="MESH" qualifier="immunology" xml:lang="en"><term>Influenza A virus</term><term>Influenza Vaccines</term><term>Orthomyxoviridae Infections</term><term>Reassortant Viruses</term></keywords><keywords scheme="MESH" qualifier="prevention & control" xml:lang="en"><term>Orthomyxoviridae Infections</term></keywords><keywords scheme="MESH" qualifier="virologie" xml:lang="fr"><term>Liquide de lavage bronchoalvéolaire</term><term>Liquide de lavage nasal</term></keywords><keywords scheme="MESH" qualifier="virology" xml:lang="en"><term>Bronchoalveolar Lavage Fluid</term><term>Nasal Lavage Fluid</term></keywords><keywords scheme="MESH" xml:lang="en"><term>Administration, Intranasal</term><term>Animals</term><term>Cell Line</term><term>Chick Embryo</term><term>Disease Models, Animal</term><term>Dogs</term><term>Ferrets</term><term>Influenza A Virus, H1N1 Subtype</term><term>Vaccination</term><term>Viral Plaque Assay</term></keywords><keywords scheme="MESH" xml:lang="fr"><term>Administration par voie nasale</term><term>Animaux</term><term>Chiens</term><term>Embryon de poulet</term><term>Furets</term><term>Infections à Orthomyxoviridae</term><term>Lignée cellulaire</term><term>Modèles animaux de maladie humaine</term><term>Méthode des plages virales</term><term>Sous-type H1N1 du virus de la grippe A</term><term>Vaccination</term></keywords></textClass></profileDesc></teiHeader><front><div type="abstract" xml:lang="en">Live, cold-adapted, temperature-sensitive (ca/ts) Russian influenza A vaccines are prepared in eggs by a 6:2 gene reassortment of the ca/ts donor strain A/Leningrad/134/17/57 (H2N2) (Len/17) with a current wild-type (wt) influenza A strain contributing hemagglutinin (HA) and neuraminidase (NA) genes. However, egg-derived reassortant vaccines are potentially more problematic to manufacture in large quantities than vaccines from cell-based procedures. To compare egg- and cell culture-derived reassortant vaccines, we prepared in Madin Darby canine kidney (MDCK) cells two cloned, ca/ts reassortants (25M/1, 39E/2) derived from Len/17 and a wt reference strain A/New Caledonia/20/99 (H1N1) (NC/wt). Both 25M/1 and 39E/2 reassortants preserved the ca/ts phenotype and mutations described for internal genes of the A/Len/17 parent. When compared to a commercial, egg-derived ca/ts Russian A/17/NC/99/145 (H1N1) New Caledonia vaccine (NC/145), the MDCK-derived reassortant 39E/2 vaccine conferred similar levels of protection in ferrets challenged i.n. with 7 x 10(10) pfu of NC/wt. In a dose-ranging study, the protective vaccine dose for 50% of ferrets (PD50) was less than 1.2 x 10(4) pfu for the 25M/1 vaccine derived by recombination and amplification in MDCK cells. Clonal isolates of ca/ts influenza A/New Caledonia/20/99 (H1N1) obtained by recombination and amplification entirely in MDCK cells can be highly protective i.n. vaccines.</div></front></TEI><affiliations><list><country><li>États-Unis</li></country></list><tree><noCountry><name sortKey="Distefano, Daniel" sort="Distefano, Daniel" uniqKey="Distefano D" first="Daniel" last="Distefano">Daniel Distefano</name><name sortKey="Johnston, Kimberly" sort="Johnston, Kimberly" uniqKey="Johnston K" first="Kimberly" last="Johnston">Kimberly Johnston</name><name sortKey="Kiseleva, Irina" sort="Kiseleva, Irina" uniqKey="Kiseleva I" first="Irina" last="Kiseleva">Irina Kiseleva</name><name sortKey="Kraiouchkine, Nikolai" sort="Kraiouchkine, Nikolai" uniqKey="Kraiouchkine N" first="Nikolai" last="Kraiouchkine">Nikolai Kraiouchkine</name><name sortKey="Kwan, Wan Sang" sort="Kwan, Wan Sang" uniqKey="Kwan W" first="Wan-Sang" last="Kwan">Wan-Sang Kwan</name><name sortKey="Monteiro, Juanita" sort="Monteiro, Juanita" uniqKey="Monteiro J" first="Juanita" last="Monteiro">Juanita Monteiro</name><name sortKey="Petrukhin, Luba" sort="Petrukhin, Luba" uniqKey="Petrukhin L" first="Luba" last="Petrukhin">Luba Petrukhin</name><name sortKey="Rubin, Boris" sort="Rubin, Boris" uniqKey="Rubin B" first="Boris" last="Rubin">Boris Rubin</name><name sortKey="Rudenko, Larisa" sort="Rudenko, Larisa" uniqKey="Rudenko L" first="Larisa" last="Rudenko">Larisa Rudenko</name><name sortKey="Shaw, Alan" sort="Shaw, Alan" uniqKey="Shaw A" first="Alan" last="Shaw">Alan Shaw</name><name sortKey="Su, Qin" sort="Su, Qin" uniqKey="Su Q" first="Qin" last="Su">Qin Su</name><name sortKey="Szymkowiak, Christopher" sort="Szymkowiak, Christopher" uniqKey="Szymkowiak C" first="Christopher" last="Szymkowiak">Christopher Szymkowiak</name><name sortKey="Toner, Timothy" sort="Toner, Timothy" uniqKey="Toner T" first="Timothy" last="Toner">Timothy Toner</name><name sortKey="Wlochowski, Joan" sort="Wlochowski, Joan" uniqKey="Wlochowski J" first="Joan" last="Wlochowski">Joan Wlochowski</name><name sortKey="Youil, Rima" sort="Youil, Rima" uniqKey="Youil R" first="Rima" last="Youil">Rima Youil</name></noCountry><country name="États-Unis"><noRegion><name sortKey="Palker, Thomas" sort="Palker, Thomas" uniqKey="Palker T" first="Thomas" last="Palker">Thomas Palker</name></noRegion></country></tree></affiliations></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Sante/explor/H2N2V1/Data/Main/Exploration
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 001653 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 001653 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Sante
|area= H2N2V1
|flux= Main
|étape= Exploration
|type= RBID
|clé= pubmed:15351492
|texte= Protective efficacy of intranasal cold-adapted influenza A/New Caledonia/20/99 (H1N1) vaccines comprised of egg- or cell culture-derived reassortants.
}}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/RBID.i -Sk "pubmed:15351492" \
| HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd \
| NlmPubMed2Wicri -a H2N2V1
| This area was generated with Dilib version V0.6.33. |  |